Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 583

1.

A comparative review of classification systems in myelodysplastic syndromes (MDS).

Bennett JM.

Semin Oncol. 2005 Aug;32(4 Suppl 5):S3-10. Review.

PMID:
16085011
2.

Evaluating the prognosis of patients with myelodysplastic syndromes.

Aul C, Giagounidis A, Germing U, Ganser A.

Ann Hematol. 2002 Sep;81(9):485-97. Epub 2002 Sep 24. Review.

PMID:
12373348
3.

International scoring system for evaluating prognosis in myelodysplastic syndromes.

Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J.

Blood. 1997 Mar 15;89(6):2079-88. Erratum in: Blood 1998 Feb 1;91(3):1100.

4.
5.

[Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].

Schmitt-Graeff A, Mattern D, Köhler H, Hezel J, Lübbert M.

Pathologe. 2000 Jan;21(1):1-15. Review. German.

PMID:
10663664
6.

The myelodysplastic syndromes: classification and prognosis.

Komrokji R, Bennett JM.

Curr Hematol Rep. 2003 May;2(3):179-85. Review.

PMID:
12901338
7.

Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.

Navarro I, Ruiz MA, Cabello A, Collado R, Ferrer R, Hueso J, Martinez J, Miguel A, Orero MT, Pérez P, Nolasco A, Carbonell F.

Leuk Res. 2006 Aug;30(8):971-7. Epub 2006 Jan 19.

PMID:
16423393
8.

World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.

Bernasconi P, Klersy C, Boni M, Cavigliano PM, Calatroni S, Giardini I, Rocca B, Zappatore R, Caresana M, Dambruoso I, Lazzarino M, Bernasconi C.

Br J Haematol. 2007 May;137(3):193-205.

PMID:
17408458
9.

Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution.

Nösslinger T, Reisner R, Koller E, Grüner H, Tüchler H, Nowotny H, Pittermann E, Pfeilstöcker M.

Blood. 2001 Nov 15;98(10):2935-41.

10.

Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.

Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K.

Leuk Res. 2004 Jun;28(6):587-94.

PMID:
15120935
11.

Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.

van de Loosdrecht AA, Westers TM, Westra AH, Dräger AM, van der Velden VH, Ossenkoppele GJ.

Blood. 2008 Feb 1;111(3):1067-77. Epub 2007 Oct 30.

12.
13.

Detection of risk groups in myelodysplastic syndromes. A multicenter study.

Belli C, Acevedo S, Bengio R, Arrossagaray G, Watman N, Rossi N, García J, Flores G, Goldztein S, Larripa I.

Haematologica. 2002 Jan;87(1):9-16.

14.

Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.

Berer A, Jäger E, Sagaster V, Streubel B, Wimazal F, Sperr WR, Welterman A, Schwarzinger I, Frommlet F, Haas OA, Valent P, Lechner K, Geissler K, Ohler L.

Ann Hematol. 2003 May;82(5):271-7. Epub 2003 Mar 22.

PMID:
12739063
15.

International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.

Kao JM, McMillan A, Greenberg PL.

Am J Hematol. 2008 Oct;83(10):765-70. doi: 10.1002/ajh.21249.

16.

[The International Prognostic Scoring System for primary myelodysplastic syndrome].

Sisková M, Dohnalová A, Neuwirtová R, Pĕnicková J, Karban J, Cmunt E.

Sb Lek. 2002;103(3):333-8. Czech.

PMID:
12688177
17.

Prognostic indicators and scoring systems for predicting outcome in patients with myelodysplastic syndromes.

Aul C, Giagounidis A, Heinsch M, Germing U, Ganser A.

Rev Clin Exp Hematol. 2004 Dec 1;8(2):E1. Review.

PMID:
16027099
18.

[Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].

Yu MH, Xu ZF, Li L, Nie L, Liu L, Zhang Y, Qin TJ, Hao YS, Xiao ZJ.

Zhonghua Xue Ye Xue Za Zhi. 2009 Jan;30(1):3-7. Chinese.

PMID:
19563026
19.

The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.

Komrokji RS, Bennett JM.

Curr Hematol Rep. 2005 May;4(3):175-81. Review.

PMID:
15865868
20.

Supplemental Content

Support Center